GO:0006481 C-terminal protein methylation: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006481 (C-terminal protein methylation) is the biological process of adding a methyl group to the C-terminal amino acid of a protein.
• This modification is catalyzed by methyltransferases and can regulate protein localization, stability, and interactions.
• C-terminal methylation is found in diverse proteins, including signaling molecules, RNA-binding proteins, and chromatin regulators.
• Dysregulation of C-terminal methylation has been linked to cancer, neurodegeneration, and viral pathogenesis.
• Key genes include PP4C, hnRNPQ, FUS, and ZBTB38, among others.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are powerful tools to study this modification and its disease relevance.
Description
C-terminal protein methylation (GO:0006481) is a post-translational modification that involves the addition of a methyl group to the carboxyl-terminal amino acid of a protein. This process is distinct from methylation at internal residues and can occur on various C-terminal amino acids, including leucine, arginine, and others. First described decades ago, C-terminal methylation has emerged as a critical regulator of protein function, influencing subcellular localization, protein-protein interactions, and stability. Researchers study this modification to understand its roles in cellular signaling, RNA processing, and chromatin dynamics, as well as its implications in diseases such as cancer and neurodegeneration. The enzymatic machinery responsible for C-terminal methylation includes specific methyltransferases, and the modification is often reversible, though the demethylases remain less characterized. Recent advances in mass spectrometry and proteomics have enabled the identification of C-terminal methylation sites on a global scale, revealing its widespread occurrence. This article provides a comprehensive overview of GO:0006481, covering its definition, mechanisms, key genes, disease associations, and research methodologies, with a focus on CRISPR-based approaches for functional studies.
C-terminal protein methylation At A Glance
| GO ID | GO:0006481 |
|---|---|
| GO term | C-terminal protein methylation |
| Ontology | biological_process |
| Synonym | C-terminal protein amino acid methylation |
| Major function | Post-translational modification that adds a methyl group to the C-terminal amino acid of a protein, regulating protein function and interactions. |
| Catalytic enzymes | Methyltransferases, including leucine methyltransferase and arginine methyltransferases. |
| Subcellular location | Cytoplasm, nucleus, and other cellular compartments depending on the substrate protein. |
| Related modifications | Protein methylation at internal residues, prenylation, and other C-terminal modifications. |
| Disease relevance | Implicated in cancer, neurodegeneration, and viral infections. |
What Is GO:0006481?
According to the Gene Ontology, GO:0006481 (C-terminal protein methylation) is defined as the methylation of the C-terminal amino acid of a protein. This biological process entails the transfer of a methyl group to the terminal carboxyl group or to the alpha-amino group of the C-terminal residue, resulting in a modified protein with altered chemical properties. The modification is catalyzed by methyltransferases and can affect protein function, localization, and interactions.
Why Is C-terminal protein methylation Important in Cell Biology?
C-terminal methylation is a crucial post-translational modification that can dramatically alter protein behavior, often acting as a molecular switch. It regulates the localization of RNA-binding proteins such as hnRNPQ, affecting RNA processing and transport. In signaling proteins, C-terminal methylation can influence membrane association and activity. The modification is also important for the function of protein phosphatases like PP4C, which is involved in cell cycle regulation and DNA damage responses. Furthermore, C-terminal methylation of proteins like FUS modulates phase separation, with implications for neurodegenerative diseases. Understanding this process is therefore essential for deciphering cellular regulatory networks and developing therapeutic strategies for related diseases.
• Regulates protein subcellular localization, as shown for hnRNPQ.
• Modulates protein-protein interactions and phase separation, e.g., FUS.
• Essential for the function of protein phosphatase PP4C in cell cycle and DNA repair.
• Influences viral protein function, such as the Sudan ebolavirus L protein.
• Plays a role in chromatin regulation via proteins like ZBTB38 and CDCA7.
• Dysregulation is associated with cancer and neurodegeneration.
• Provides a mechanism for dynamic regulation of signaling pathways.
• Can be studied using advanced proteomic methods like LysargiNase digestion.
• Represents a potential target for therapeutic intervention in diseases.
• CRISPR-based models enable precise functional dissection of methylation sites.
What Happens During C-terminal protein methylation?
Substrate Recognition and Methyltransferase Recruitment
In simple terms: First, the enzyme that adds the methyl group finds its target protein.
C-terminal methylation begins with the recognition of a substrate protein by a specific methyltransferase. The enzyme binds to the C-terminal region of the target, often recognizing a consensus sequence or structural motif. For example, the leucine methyltransferase recognizes the C-terminal leucine of PP4C. In the case of FUS, methylation of arginine residues in the C-terminal domain is mediated by protein arginine methyltransferases, which are recruited through interactions with chaperones. This step ensures specificity and is regulated by cellular signals.
Methyl Group Transfer
In simple terms: The enzyme then attaches a methyl group to the end of the protein.
The methyltransferase catalyzes the transfer of a methyl group from S-adenosylmethionine (SAM) to the C-terminal amino acid of the substrate. This can occur on the alpha-amino group, as in leucine methylation of PP4C, or on the guanidino group of arginine, as in FUS. The reaction results in a covalent modification that alters the chemical properties of the protein terminus. The methylation is often irreversible without a demethylase, though some demethylases exist.
Conformational and Functional Consequences
In simple terms: The added methyl group changes how the protein behaves.
Methylation can induce conformational changes that affect protein stability, interactions, and localization. For hnRNPQ, C-terminal methylation is important for its nuclear localization, likely by modulating interactions with import receptors. In FUS, methylation of arginine residues in the C-terminal domain reduces phase separation and prevents pathological aggregation. Similarly, methylation of PP4C is critical for its phosphatase activity and cellular functions. These functional consequences underscore the regulatory importance of C-terminal methylation.
Regulation and Reversibility
In simple terms: The process can be turned on and off by other enzymes.
C-terminal methylation is dynamically regulated. While methyltransferases add the mark, demethylases can remove it, though specific C-terminal demethylases are less characterized. The activity of methyltransferases can be modulated by cellular signals, such as during stress or cell cycle progression. For instance, the methylation of FUS is influenced by the chaperone system, which affects its aggregation propensity. This regulation ensures that C-terminal methylation is responsive to cellular needs.
Key Genes Involved in GO:0006481 C-terminal protein methylation
The following genes encode proteins that are either substrates or enzymes involved in C-terminal protein methylation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PPP4C | Protein phosphatase 4 catalytic subunit; C-terminal leucine methylation is critical for its function. | Cell cycle regulation, DNA damage response, cancer. |
| HNRNPQ | RNA-binding protein; C-terminal methylation important for nuclear localization. | RNA processing, transport, cancer. |
| FUS | RNA-binding protein; arginine methylation in C-terminal domain modulates phase separation. | Neurodegeneration (ALS, FTD), phase separation. |
| ZBTB38 | Transcription factor; C-terminal zinc fingers read DNA methylation. | Epigenetic regulation, cancer. |
| CDCA7 | Chromatin remodeling factor; C-terminal 4CXXC zinc finger recognizes hemimethylated DNA. | Chromatin dynamics, cancer. |
| PRMT1 | Protein arginine methyltransferase; may methylate C-terminal arginines. | Epigenetics, cancer, neurodegeneration. |
| PRMT5 | Protein arginine methyltransferase; potential role in C-terminal methylation. | Cancer, stem cell biology. |
| LCMT1 | Leucine carboxyl methyltransferase; methylates PP2A and PP4C. | Phosphatase regulation, cancer. |
| LCMT2 | Leucine carboxyl methyltransferase; potential role in C-terminal methylation. | Phosphatase regulation. |
| METTL | Methyltransferase-like proteins; some may act on C-terminal residues. | Epitranscriptomics, cancer. |
| EBOV L | Ebolavirus RNA polymerase; C-terminal domain essential for RNA binding and methylation. | Viral replication, antiviral targets. |
| NSAP1 | Splicing factor; C-terminal methylation affects nuclear localization. | RNA splicing, cancer. |
| PP2A | Protein phosphatase 2A; C-terminal leucine methylation regulates activity. | Signaling, cancer. |
| RAS | Small GTPase; C-terminal methylation modulates membrane association. | Cancer signaling. |
| RHO | Small GTPase; C-terminal methylation affects function. | Cytoskeleton, cancer. |
| CDC42 | Small GTPase; C-terminal methylation may regulate activity. | Cell polarity, cancer. |
| RAB | Small GTPase; C-terminal methylation influences trafficking. | Vesicle transport, cancer. |
| HSP70 | Chaperone; modulates FUS methylation and phase separation. | Protein folding, neurodegeneration. |
How Is C-terminal protein methylation Regulated?
C-terminal methylation is regulated at multiple levels. The expression and activity of methyltransferases are controlled by cellular signals, including growth factors and stress pathways. For instance, the methylation of FUS is modulated by the chaperone HSP70, which affects its phase separation and aggregation. Additionally, the availability of the methyl donor S-adenosylmethionine (SAM) can influence methylation rates. Demethylases, though less characterized, provide reversibility. In viral infections, the C-terminal domain of the ebolavirus L protein is essential for RNA binding and methylation, highlighting pathogen-specific regulation. Overall, regulation ensures that C-terminal methylation is dynamic and context-dependent.
C-terminal protein methylation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PPP4C | Cancer, DNA damage response | Knockout and point-mutation cell lines to study methylation site. |
| FUS | ALS, FTD, phase separation | Knock-in of methylation-deficient mutants, overexpression. |
| HNRNPQ | Cancer, RNA processing | Knockout and tagged knock-in for localization studies. |
| ZBTB38 | Cancer, epigenetic regulation | Knockout and overexpression models. |
| EBOV L | Viral infection | Overexpression of C-terminal domain mutants. |
C-terminal methylation in cancer
Dysregulation of C-terminal methylation has been implicated in cancer. For example, the methylation of PP4C is critical for its function in DNA damage repair, and loss of this modification may contribute to genomic instability and tumorigenesis. Similarly, hnRNPQ methylation affects nuclear localization, and its misregulation could alter RNA processing in cancer cells. ZBTB38, a transcription factor with C-terminal zinc fingers, reads DNA methylation and is involved in epigenetic regulation, with potential roles in cancer. Targeting the enzymes responsible for C-terminal methylation may offer therapeutic opportunities.
C-terminal methylation in neurodegeneration
In neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), aberrant phase separation of FUS is a hallmark. Methylation of arginine residues in the C-terminal domain of FUS reduces its phase separation and aggregation, suggesting that dysregulation of this methylation contributes to disease. The chaperone system, including HSP70, modulates FUS methylation and aggregation, providing a potential therapeutic target.
C-terminal methylation in viral infections
The C-terminal domain of the Sudan ebolavirus L protein is essential for RNA binding and methylation, which are critical for viral replication. This highlights how viruses exploit C-terminal methylation for their life cycle. Understanding these mechanisms could inform antiviral drug development.
From C-terminal protein methylation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does C-terminal methylation of PP4C regulate its phosphatase activity? | Point mutation of the C-terminal leucine to alanine (methylation-deficient). |
| How does FUS methylation affect phase separation? | Knock-in of methylation-mimetic or deficient mutants. |
| What is the role of hnRNPQ methylation in nuclear localization? | Knockout and rescue with wild-type or methylation-deficient hnRNPQ. |
| Does ZBTB38 C-terminal zinc finger bind methylated DNA? | Knockout and overexpression of ZBTB38 mutants. |
| Is the ebolavirus L protein C-terminal domain required for methylation? | Overexpression of truncated or point-mutated L protein. |
| Can CRISPR screening identify novel C-terminal methyltransferases? | Genome-wide CRISPR knockout library screening. |
How to Study the C-terminal protein methylation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LysargiNase digestion + LC-MS/MS | C-terminal peptides and methylation sites | Global profiling of C-terminal methylation. |
| Western blot with methylation-specific antibodies | Presence and levels of methylated proteins | Validation of specific methylation events. |
| CRISPR-Cas9 knockout | Loss of gene function | Studying the role of methyltransferases. |
| CRISPR point mutation | Effect of specific methylation site mutation | Dissecting functional significance of C-terminal methylation. |
| Knock-in of tagged proteins | Localization and interactions of methylated proteins | Live-cell imaging and proteomics. |
| Overexpression | Gain-of-function effects | Studying dominant-active or -negative mutants. |
| In vitro methylation assay | Enzymatic activity of methyltransferases | Kinetic studies and inhibitor screening. |
| Proximity ligation assay | Protein-protein interactions in situ | Detecting methylation-dependent interactions. |
Mass spectrometry-based proteomics
Mass spectrometry is a key method for identifying and quantifying C-terminal methylation. The use of LysargiNase, which cleaves before arginine and lysine residues, enhances the identification of protein C-termini and methylation sites. This approach enables global profiling of C-terminal methylation across the proteome.
Antibody-based detection
Specific antibodies against methylated C-terminal residues can be used in Western blotting, immunoprecipitation, and immunofluorescence to detect and localize methylated proteins. For example, antibodies against methylated PP4C have been used to study its regulation.
CRISPR-Cas9 genome editing
CRISPR-Cas9 allows precise modification of genes encoding methyltransferases or their substrates. Knockout, point mutation, knock-in, and overexpression models can be generated to study the functional consequences of C-terminal methylation.
Biochemical assays
In vitro methylation assays using recombinant enzymes and substrates can measure methyltransferase activity. These assays often use radioactive SAM or fluorescent probes to detect methyl group transfer.
How CRISPR Can Be Used to Study GO:0006481 C-terminal protein methylation
Knockout
CRISPR knockout of genes encoding C-terminal methyltransferases or their substrates can reveal loss-of-function phenotypes. For example, knocking out PPP4C or its methyltransferase LCMT1 can abolish C-terminal methylation and affect cell cycle progression. Knockout models are essential for understanding the physiological roles of C-terminal methylation.
Point Mutation
Introducing point mutations at the C-terminal methylation site (e.g., leucine to alanine in PP4C) prevents methylation and allows assessment of its specific contribution to protein function. This approach is highly precise and avoids confounding effects from complete gene deletion.
Knock-in
Knock-in of tagged or mutant versions of proteins (e.g., FLAG-tagged hnRNPQ) enables tracking of localization and interactions. Knock-in of methylation-mimetic (e.g., leucine to methionine) or deficient mutants can mimic or block methylation, respectively.
Overexpression
Overexpression of wild-type or mutant proteins (e.g., FUS) can model gain-of-function effects and study phase separation. Overexpression of methyltransferases can enhance C-terminal methylation and reveal downstream effects.
How EDITGENE Supports C-terminal protein methylation Research
Researchers studying C-terminal protein methylation-related genes often need to determine whether a candidate gene is causally involved in a specific cellular process or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to facilitate these investigations, from gene knockout to precise point mutations and knock-in models.
Contact EDITGENE today to design your custom CRISPR model for C-terminal protein methylation research.
Frequently Asked Questions About C-terminal protein methylation
What is C-terminal protein methylation?
C-terminal protein methylation (GO:0006481) is the post-translational addition of a methyl group to the C-terminal amino acid of a protein, which can regulate its function, localization, and interactions.
What genes are involved in C-terminal protein methylation?
Key genes include PPP4C, HNRNPQ, FUS, ZBTB38, CDCA7, and methyltransferases like PRMT1 and LCMT1.
How is C-terminal methylation detected?
It can be detected using mass spectrometry with LysargiNase digestion, methylation-specific antibodies, and biochemical assays.
What diseases are associated with C-terminal methylation?
It is implicated in cancer, neurodegeneration (e.g., ALS), and viral infections.
Can CRISPR be used to study C-terminal methylation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to study this modification.
What is the role of FUS methylation?
Methylation of arginine residues in the C-terminal domain of FUS reduces its phase separation and aggregation, which is relevant to ALS.
How does C-terminal methylation affect protein localization?
Methylation can modulate interactions with transport receptors; for example, hnRNPQ methylation is important for its nuclear localization.
Is C-terminal methylation reversible?
Yes, though specific demethylases are less characterized, the modification can be removed by demethylases.
What is the C-terminal domain of ebolavirus L protein?
It is essential for RNA binding and methylation, critical for viral replication.
What methods are used to study C-terminal methylation?
Mass spectrometry, Western blotting, CRISPR editing, and in vitro assays are commonly used.
Conclusion
C-terminal protein methylation (GO:0006481) is a critical post-translational modification that regulates diverse cellular processes, from RNA processing to signal transduction. Its dysregulation is linked to cancer, neurodegeneration, and viral infections. Advances in proteomics and CRISPR-based genome editing have accelerated our understanding of this modification, revealing key enzymes and substrate proteins. Continued research into C-terminal methylation will likely uncover new therapeutic targets and deepen our knowledge of cellular regulation.
References
- 1. Qamar S et al.. 2018. FUS Phase Separation Is Modulated by a Molecular Chaperone and Methylation of Arginine Cation-π Interactions.. Cell 173(3):720-734.e15 PMID: 29677515
- 2. Valle C et al.. 2020. The C-Terminal Domain of the Sudan Ebolavirus L Protein Is Essential for RNA Binding and Methylation.. J Virol 94(12) PMID: 32269120
- 3. Huesgen PF et al.. 2015. LysargiNase mirrors trypsin for protein C-terminal and methylation-site identification.. Nat Methods 12(1):55-8 PMID: 25419962
- 4. Passos DO et al.. 2006. The methylation of the C-terminal region of hnRNPQ (NSAP1) is important for its nuclear localization.. Biochem Biophys Res Commun 346(2):517-25 PMID: 16765914
- 5. Shinkai A et al.. 2024. The C-terminal 4CXXC-type zinc finger domain of CDCA7 recognizes hemimethylated DNA and modulates activities of chromatin remodeling enzyme HELLS.. Nucleic Acids Res 52(17):10194-10219 PMID: 39142653
- 6. Hrycyna CA et al.. 1993. Modification of eukaryotic signaling proteins by C-terminal methylation reactions.. Pharmacol Ther 59(3):281-300 PMID: 8309992
- 7. Lee J et al.. 2014. Leucine methylation of protein phosphatase PP4C at C-terminal is critical for its cellular functions.. Biochem Biophys Res Commun 452(1):42-7 PMID: 25130464
- 8. Pozner A et al.. 2018. The C-Terminal Zinc Fingers of ZBTB38 are Novel Selective Readers of DNA Methylation.. J Mol Biol 430(3):258-271 PMID: 29287967
